<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>19(3)</volume><submitter>Astaire E</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>Depression is an increasingly common mental health disorder in the UK, managed predominantly in the community by GPs. Emerging evidence suggests lifestyle medicine is a key component in the management of depression. We aimed to explore GPs' experiences, attitudes, and challenges to providing lifestyle advice to patients with depression.&lt;h4>Method&lt;/h4>Focus groups were conducted virtually with UK GPs (May-July 2022). A topic guide facilitated the discussion and included questions on experiences, current practices, competence, challenges, and service provision. Data were analysed using template analysis.&lt;h4>Results&lt;/h4>'Supporting Effective Conversations'; 'Willing, but Blocked from Establishing Relational Care'; 'Working Towards Patient Empowerment'; and 'Control Over the Prognosis' were all elements of how individualised lifestyle advice was key to the management of depression. Establishing a doctor-patient relationship by building trust and rapport was fundamental to having effective conversations about lifestyle behaviours. Empowering patients to make positive lifestyle changes required tailoring advice using a patient-centred approach. Confidence varied across participants, depending on education, experience, type of patient, and severity of depression.&lt;h4>Conclusions&lt;/h4>GPs play an important role in managing depression using lifestyle medicine and a patient-centred approach. Organisational and educational changes are necessary to facilitate GPs in providing optimal care to patients with depression.</pubmed_abstract><journal>PloS one</journal><pagination>e0299934</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10927082</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>General practitioners' experiences of providing lifestyle advice to patients with depression: A qualitative focus group study.</pubmed_title><pmcid>PMC10927082</pmcid><pubmed_authors>Flynn AC</pubmed_authors><pubmed_authors>Khundakar M</pubmed_authors><pubmed_authors>Jennings L</pubmed_authors><pubmed_authors>Silverio SA</pubmed_authors><pubmed_authors>Astaire E</pubmed_authors></additional><is_claimable>false</is_claimable><name>General practitioners' experiences of providing lifestyle advice to patients with depression: A qualitative focus group study.</name><description>&lt;h4>Objective&lt;/h4>Depression is an increasingly common mental health disorder in the UK, managed predominantly in the community by GPs. Emerging evidence suggests lifestyle medicine is a key component in the management of depression. We aimed to explore GPs' experiences, attitudes, and challenges to providing lifestyle advice to patients with depression.&lt;h4>Method&lt;/h4>Focus groups were conducted virtually with UK GPs (May-July 2022). A topic guide facilitated the discussion and included questions on experiences, current practices, competence, challenges, and service provision. Data were analysed using template analysis.&lt;h4>Results&lt;/h4>'Supporting Effective Conversations'; 'Willing, but Blocked from Establishing Relational Care'; 'Working Towards Patient Empowerment'; and 'Control Over the Prognosis' were all elements of how individualised lifestyle advice was key to the management of depression. Establishing a doctor-patient relationship by building trust and rapport was fundamental to having effective conversations about lifestyle behaviours. Empowering patients to make positive lifestyle changes required tailoring advice using a patient-centred approach. Confidence varied across participants, depending on education, experience, type of patient, and severity of depression.&lt;h4>Conclusions&lt;/h4>GPs play an important role in managing depression using lifestyle medicine and a patient-centred approach. Organisational and educational changes are necessary to facilitate GPs in providing optimal care to patients with depression.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024</publication><modification>2026-06-27T03:15:53.07Z</modification><creation>2025-04-06T01:42:15.597Z</creation></dates><accession>S-EPMC10927082</accession><cross_references><pubmed>38466705</pubmed><doi>10.1371/journal.pone.0299934</doi></cross_references></HashMap>